Tepnel Announces New DNA Test For Early Detection Of Familial Hypercholesterolaemia
Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC (AIM: TED) today announced the launch of a DNA test for the early detection of FH, a genetic condition that predisposes individuals to high blood cholesterol levels and increased risk of cardiovascular disease.
More: continued here
Filed under: Cholesterol on September 8th, 2008